EcoDrugPlus

Cf Transmembrane Conductance Regulator

Ensembl ID : ENSDLEG00000009386
Gene Symbol: CFTR
1 Cross references
217 Possible Orthologues:

Dna Methyltransferase 1

Ensembl ID : ENSDLEG00000008585
Gene Symbol: DNMT1
1 Cross references
212 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSDLEG00000004091
Gene Symbol: TOP1
1 Cross references
273 Possible Orthologues:

Dna Topoisomerase Ii Alpha

Ensembl ID : ENSDLEG00000011757
Gene Symbol: TOP2A
3 Cross references
206 Possible Orthologues:

Dna Topoisomerase Ii Beta

Ensembl ID : ENSDLEG00000008704
Gene Symbol: TOP2B
3 Cross references
210 Possible Orthologues:

Eph Receptor A2

Ensembl ID : ENSDLEG00000013587
Gene Symbol: EPHA2
3 Cross references
124 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSDLEG00000011806
Gene Symbol: EPHA3
3 Cross references
216 Possible Orthologues:

Eph Receptor B4

Ensembl ID : ENSDLEG00000008456
Gene Symbol: EPHB4
3 Cross references
168 Possible Orthologues:

F2r Like Thrombin Or Trypsin Receptor 3

Ensembl ID : ENSDLEG00000000796
Gene Symbol: F2RL3
3 Cross references
193 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSDLEG00000008452
Gene Symbol: FYN
3 Cross references
264 Possible Orthologues:

G Protein-Coupled Receptor 119

Ensembl ID : ENSDLEG00000009279
Gene Symbol: GPR119
3 Cross references
176 Possible Orthologues:

G Protein-Coupled Receptor 84

Ensembl ID : ENSDLEG00000006731
Gene Symbol: GPR84
3 Cross references
124 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).